Corden Pharma International GmbH
Corden Pharma International GmbH, a leading contract development and manufacturing organisation (CDMO), is headquartered in Germany and operates across Europe and North America. Founded in 2006, the company has established itself in the pharmaceutical and biotechnology sectors, specialising in the development and production of complex drug formulations, including injectables and oral solid dosage forms. Corden Pharma is renowned for its comprehensive range of services, from early-stage development to commercial manufacturing, with a strong emphasis on quality and regulatory compliance. The company’s unique capabilities in custom synthesis and formulation development set it apart in a competitive market. With a commitment to innovation and excellence, Corden Pharma has achieved significant milestones, positioning itself as a trusted partner for clients seeking reliable and efficient solutions in the pharmaceutical landscape.
DitchCarbon Score
How does Corden Pharma International GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Corden Pharma International GmbH's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Corden Pharma International GmbH's reported carbon emissions
Corden Pharma International GmbH, headquartered in Germany, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Corden Pharma may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and climate action, often setting science-based targets to align with global climate goals. However, without specific emissions data or commitments from Corden Pharma, it is unclear how the company is addressing its environmental impact. As the industry evolves, it is anticipated that Corden Pharma will consider implementing climate initiatives to enhance transparency and contribute to broader sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Corden Pharma International GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
